$ORLY Overall Average: 8% Sell. $ORLY $SLX $BNFT O'Reilly

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Today's Monumental Achievements in the Stock Market: S&P 500 and Nasdaq 100 Hit Record Highs, Nvidia Surpasses Apple in Market Value Analyzing Today's Market Milestones Important milestones were hit in today's financial markets, that not only reflect the strength of the market, but point towards changing patterns within the tech industry. Two of the most followed indices,...

Expansion of Knight Therapeutics and Helsinn Partnership MONTREAL and LUGANO, Switzerland – Knight Therapeutics Inc. (TSX: GUD), a pan-American specialty pharmaceutical company, has taken significant steps to enhance its partnership with Helsinn Healthcare SA, a well-respected global pharmaceutical company. This collaboration will focus on an exclusive license,...

Empowering Houstonians: A Community Event for Disaster Preparedness Whitestone Developments in collaboration with Empower CDC are taking a remarkable step to ensure families are prepared for emergencies. They are hosting a community event focused on disaster preparedness that promises to be educational and engaging. This initiative, titled "Get Ready, Houston!", aims to...

A New Era of Sustainable Urban Development In an inspiring event held on November 1 in Bogota, a significant gathering took place centered around sustainable urban development. This thematic session was part of the 2025 Global Observance of World Cities Day, marking an important milestone in addressing environmental concerns globally. Participation and Significance of the...

Geotab® Enhances Fleet Management with Telematics Solutions Geotab Inc. has taken a significant step towards improving operational efficiency by partnering with the Delaware Department of Transportation (DelDOT). This collaboration aims to leverage data insights and artificial intelligence to boost efficiency and promote sustainability in governmental fleet operations....